当前位置：首页 > 文献互助 > 互助详情

Aldosterone and the Mineralocorticoid Receptor in Atrial Fibrillation复制

用户HyRiO5PgvTqQ 1小时前 10 10 待确认 帖子自动结束时间: 2026-03-04 16:07:09

1. 请及时下载文件确认是否正确, 系统将在 2026-03-06 17:00:59 删除文件

2. 如若文件有误请驳回应助文件, 求助状态即回到求助中

3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1161/HYPERTENSIONAHA.125.26187复制

文献链接: https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.125.26187复制

其他信息:

出版社: Ovid Technologies (Wolters Kluwer Health)
作者: Argen Mamazhakypov; Remi Peyronnet; Achim Lother

上一篇：Emerging Medical Therapies for Primary Aldosteronism

下一篇：† Obicetrapib alone and in combination with ezetimibe increases reverse cholesterol transport and does not affect VLDL production

互助时间线

2026-02-27 17:00:59 [上传文件]

向日葵2024上传了文件(pdf 1.22 MB), 求助状态变成 待确认

2026-02-27 16:07:09 [发起求助]

最新发布的求助

Design, synthesis and anti-breast cancer activity evaluation of 6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidine-based PARP1/ATR dual inhibitors 27分钟前
Synthesis of Unsymmetrical Ketones Using Chelation-Controlled Sequential Substitution of N-Triazinylamide/Weinreb Amide by Organometallic Reagents 1小时前
Development of a dual functional RNAi therapeutic, ARO-DIMER-PA, for mixed hyperlipidemia 1小时前
Fine-Tuning the Active-Site Microenvironment of β-Galactosidase to Enhance the Synthesis Ability of Galactooligosaccharides while Minimizing the Impairment to Transglycosylation Activity 1小时前
Development of a dual functional RNAi therapeutic, ARO-DIMER-PA, for mixed hyperlipidemia 1小时前
† Obicetrapib alone and in combination with ezetimibe increases reverse cholesterol transport and does not affect VLDL production 1小时前
Aldosterone and the Mineralocorticoid Receptor in Atrial Fibrillation 1小时前
Emerging Medical Therapies for Primary Aldosteronism 1小时前
Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer 2小时前
Biomarkers for Cardiovascular Drug Development 2小时前
Heart Failure Prevention 2小时前
Neurochemical Characteristics of Amisulpride, an Atypical Dopamine D2/D3 Receptor Antagonist with Both Presynaptic and Limbic Selectivity 2小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com